These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 927326)

  • 1. [Treatment with Hepavis, a new cholerectically-active hepaticum. Experiences from an internal medicine profemoral practice].
    Stuchlik S
    Med Monatsschr; 1977 Nov; 31(11):524-6. PubMed ID: 927326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reflections on medicamentous liver-therapy. Hepavis in medical practice].
    Wegener W
    Med Monatsschr; 1977 Jul; 31(7):328-30. PubMed ID: 904570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience report on Hepavis].
    Menninger U; Menninger W
    Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with the oral liver-therapeutic agent Hepavis].
    Bayazid A; Gerhard W
    Med Welt; 1976 Nov; 27(46):2248-9. PubMed ID: 794616
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of alcoholic toxic fatty liver. A placebo-controlled trial with hepavis (author's transl)].
    Deynet G; Reimer F
    MMW Munch Med Wochenschr; 1979 Jun; 121(24):831-2. PubMed ID: 111085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?].
    Odegaard S; Busch D
    Z Gastroenterol; 1989 Feb; 27(2):91-3. PubMed ID: 2658394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Repair, regeneration and metabolism of liver cells: a clinical report].
    Blasy J
    ZFA (Stuttgart); 1979 Apr; 55(12):787-91. PubMed ID: 375610
    [No Abstract]   [Full Text] [Related]  

  • 8. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E
    Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of liver diseases with Hepatofalk].
    Hirsch W; Smerlings H
    Ther Ggw; 1976 Oct; 115(10):1719-54. PubMed ID: 136762
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled clinical trial of a new combination of phosphorylcholine, homocysteine-gamma-thiolactone and vitamin B 12 in the parenteral treatment of chronic hepatopathies].
    Bandini S; Monteforte S
    Clin Ter; 1974 Jun; 69(6):549-60. PubMed ID: 4845637
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
    Mariani B; Marchioni GF; Capitolo S
    Minerva Med; 1974 Aug; 65(57):2977-89. PubMed ID: 4603931
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental clinical study of the new product C-29 (Vedrenan) in hepatobiliary processes].
    García García FJ; Velo Vellver JL; Torres Segovia J; Cos Arregui E; Alcala Santaella R
    Rev Esp Enferm Apar Dig; 1972 Mar; 36(5):593-602. PubMed ID: 5013208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of a new preparation with liver-protective and anti-anemic action].
    Cairella M
    Clin Ter; 1966 Dec; 39(6):567-76. PubMed ID: 4232883
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of a new hepatoprotective preparation].
    Azzena D
    Clin Ter; 1972 Jan; 60(2):143-8. PubMed ID: 5015349
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepa-listrocol in the therapy of chronic inflammatory liver diseases].
    Baum HH
    Landarzt; 1967 Apr; 43(11):530-3. PubMed ID: 5585071
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effect of a pharmacologic combination of choleretics and digestive enzymes in exocrine pancreatic insufficiency].
    Ventrucci M; Bolondi L; Caletti GC; Fontana G
    Minerva Med; 1975 Mar; 66(17):819-23. PubMed ID: 48215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experiences with the amphocholereticum Oddibil].
    Zawodsky L
    Wien Med Wochenschr; 1974 Nov; 124(46):677-80. PubMed ID: 4617977
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G; Maggi P; Benvenuti C
    Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
    Martinelli M; Albini U; Villecco A
    Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
    Fernández Navarro MD; García Pérez M; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.